Akkermansia muciniphila improves gastric cancer treatment by modulating the immune microenvironment
At week 68, the mean weight reduction in the CagriSema group was 13.7%, compared with 3.4% in the placebo group, yielding a significant between-group difference of 10.4% (95% CI: 11.29.5
Discover the benefits of tirzepatide, an advanced weight loss solution that works by curbing cravings, supporting fat loss, and promoting a healthier metabolism
Cell viability assay 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), diluted in PBS to 0.5 mg/mL, was added to a 96-well plate at 100 L per well, where STC-1 or NIT-1 cells were cultured
32 HuangL.YinX.LiW.CaoY.ChenY.LaoL.et al (2021)
doi: 10.2147/IJWH.S345853 142 AminiLTehranianNMovahedinMRamezani TehraniFZiaeeS